Please use this identifier to cite or link to this item: http://repositorio.ufla.br/jspui/handle/1/28475
Title: Exploring MIA-QSARs for farnesyltransferase inhibitory effect of antimalarial compounds refined by docking simulations
Keywords: Farnesyltransferase Inhibitors
Analysis-QSAR
Docking simulations
Antimalarial compounds
Inibidores da farnesiltransferase
Análise-QSAR
Simulações de encaixe
Compostos antimaláricos
Issue Date: 2012
Publisher: Scientific Research
Citation: DEEB, O. et al. Exploring MIA-QSARs for farnesyltransferase inhibitory effect of antimalarial compounds refined by docking simulations. Journal of Biophysical Chemistry, [S. l.], v. 3, n. 1, p. 58-71, 2012.
Abstract: Two series of farnesyltransferase (FTase) inhibi- tors were grouped and their antimalarial activi-ties modeled by means of multivariate image analysis applied to quantitative structure-activ- ity relationship (MIA-QSAR). A reliable model was achieved, with r2 for calibration, external prediction and leave-one-out cross-validation of 0.96, 0.87 and 0.83, respectively. Therefore, bio-logical activities of congeners can be estimated using the QSAR model. The bioactivities of new compounds based on the miscellany of sub-structures of the two classes of FTase inhibitors were predicted using the MIA-QSAR model and the most promising ones were submitted to ADME (absorption, distribution, metabolism and excretion) and docking evaluation. Despite the smaller interaction energy of the two most pro-mising, predicted compounds in comparison to the two most active compounds of the data set, one of the proposed structures did not violate any Lipinski’s rule of five. Therefore, it is either a potential drug or may drive synthesis of similar, improved compounds.
URI: http://file.scirp.org/Html/17180.html
http://repositorio.ufla.br/jspui/handle/1/28475
Appears in Collections:DQI - Artigos publicados em periódicos

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.